0001640455-20-000107.txt : 20200818 0001640455-20-000107.hdr.sgml : 20200818 20200818202945 ACCESSION NUMBER: 0001640455-20-000107 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200814 FILED AS OF DATE: 20200818 DATE AS OF CHANGE: 20200818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cole Hugh M CENTRAL INDEX KEY: 0001604646 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37998 FILM NUMBER: 201115086 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS, INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 454870634 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_159779697050853.xml FORM 4 X0306 4 2020-08-14 0 0001640455 Jounce Therapeutics, Inc. JNCE 0001604646 Cole Hugh M C/O JOUNCE THERAPEUTICS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 0 1 0 0 Chief Business Officer Common Stock 2020-08-14 4 S 0 984 4.64 D 62606 D Common Stock 2020-08-17 4 S 0 454 4.86 D 62152 D Common Stock 2020-08-18 4 S 0 744 4.71 D 61408 D Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Represents the weighted average share price of an aggregate total of 984 shares sold in the price range of $4.55 to $4.75 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 454 shares sold in the price range of $4.72 to $5.05 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 744 shares sold in the price range of $4.67 to $4.92 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Caroline Gammill, Attorney-in-fact 2020-08-18